David B. Weiner - 11 Aug 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ David B. Weiner
Issuer symbol
INO
Transactions as of
11 Aug 2022
Transactions value $
-$5,938
Form type
4
Filing time
11 Aug 2022, 16:15:42 UTC
Previous filing
17 May 2022
Next filing
28 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise $25.7K +11.9K +1.33% $2.16 905K 11 Aug 2022 Direct
transaction INO Common Stock Sale -$31.6K -11.9K -1.31% $2.66* 893K 11 Aug 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Common Stock Option Options Exercise $0 -11.9K -50% $0.00 11.9K 11 Aug 2022 Common Stock 11.9K $2.16 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 These transactions were executed in multiple trades at prices ranging from $2.66 to $2.69, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014.